Results 121 to 130 of about 30,079 (265)

IL‐33 Drives Inflammatory Changes and Extracellular Trap Formation in Eosinophils Involving Oxidised LDL and Complement Pathways

open access: yesAllergy, EarlyView.
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama   +16 more
wiley   +1 more source

Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev   +5 more
wiley   +1 more source

Eosinophil granulomatosis polyangiitissel: esetbemutatások és irodalmi áttekintés [PDF]

open access: yes, 2018
L
Herédi, Emese   +4 more
core   +1 more source

Granulomatosis With Polyangiitis (Wegener Granulomatosis): Then and Now

open access: yesArchives of Pathology & Laboratory Medicine
Context.— In 1954 Godman and Churg published an article in the Archives of Pathology & Laboratory Medicine entitled “Wegener’s Granulomatosis” (now replaced by “granulomatosis with polyangiitis” [GPA]) and linked various forms of what is ...
Andrew, Churg, Nestor L, Muller
openaire   +2 more sources

Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple   +30 more
wiley   +1 more source

Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure [PDF]

open access: yes, 2015
Chronic nasal carriage of the bacterium Staphylococcus aureus in patients with the autoimmune disease granulomatosis with polyangiitis (GPA) is a risk factor for disease relapse.
Arends, J.P.A. (Jan)   +18 more
core   +1 more source

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

open access: yesNature Reviews Rheumatology, 2023
G. Emmi   +29 more
semanticscholar   +1 more source

Fulminant Wegener's granulomatosis: A case report [PDF]

open access: yes, 2013
Introduction. Granulomatosis Wegener is anti-neutrophil cytoplasmic antibodies (ANCAs)-associated systemic vasculitis of unknown etiology. It is manifested as granulomatous necrotizing inflammation of the upper and lower parts of the respiratory tract,
Dinić Miroslav Ž.   +3 more
core   +1 more source

Ventricular Thrombus Formation Caused by Subendomyocardial Inflammation in Eosinophilic Granulomatosis With Polyangiitis

open access: yesJACC: Case Reports
Cardiac involvement of eosinophilic granulomatosis with polyangiitis is a rare but life-threatening complication. We present a case of eosinophilic granulomatosis with polyangiitis with moderately impaired ventricular function forming a ventricular ...
Naoyuki Takahashi, MD   +9 more
doaj   +1 more source

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's) [PDF]

open access: yes, 2011
Objective Standard treatment for severe granulomatosis with polyangiitis (Wegener's) (GPA) is daily oral cyclophosphamide (CYC), a cytotoxic agent associated with ovarian failure.
Allen, Nancy B.   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy